---
figid: PMC3884108__ijgm-6-877Fig2
figtitle: Cell mechanism linking impaired glucose utilization in type 2 diabetes and
  cardiovascular disease
organisms:
- NA
pmcid: PMC3884108
filename: ijgm-6-877Fig2.jpg
figlink: /pmc/articles/PMC3884108/figure/f2-ijgm-6-877/
number: F2
caption: 'Cell mechanism linking impaired glucose utilization in type 2 diabetes and
  cardiovascular disease. Insulin signal transduction in individuals with normal glucose
  tolerance (A) and with type 2 diabetes (B). Insulin signaling through IRS-1 is impaired
  in type 2 diabetes, leading to decreased glucose transport/phosphorylation/metabolism
  and impaired NOS activation/endothelial function. Insulin resistance in the IRS-1/PI-3
  kinase pathway results in compensatory hyperinsulinemia, excessive stimulation of
  the MAP kinase pathway, and subsequent inflammation, cell proliferation, and atherogenesis.Abbreviations:
  IRS-1, insulin-receptor substrate 1; NOS, nitric oxide synthase; PI-3, phosphoinositide
  3; MAP, mitogen-activated protein; SHC, Src-homology collagen.'
papertitle: 'Pathogenesis and management of postprandial hyperglycemia: role of incretin-based
  therapies.'
reftext: John Gerich. Int J Gen Med. 2013;6:877-895.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9597009
figid_alias: PMC3884108__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC3884108__F2
ndex: c7b2a8f6-deb6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3884108__ijgm-6-877Fig2.html
  '@type': Dataset
  description: 'Cell mechanism linking impaired glucose utilization in type 2 diabetes
    and cardiovascular disease. Insulin signal transduction in individuals with normal
    glucose tolerance (A) and with type 2 diabetes (B). Insulin signaling through
    IRS-1 is impaired in type 2 diabetes, leading to decreased glucose transport/phosphorylation/metabolism
    and impaired NOS activation/endothelial function. Insulin resistance in the IRS-1/PI-3
    kinase pathway results in compensatory hyperinsulinemia, excessive stimulation
    of the MAP kinase pathway, and subsequent inflammation, cell proliferation, and
    atherogenesis.Abbreviations: IRS-1, insulin-receptor substrate 1; NOS, nitric
    oxide synthase; PI-3, phosphoinositide 3; MAP, mitogen-activated protein; SHC,
    Src-homology collagen.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Eaat1
  - Glut1
  - Glut4EF
  - Glut3
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Akt
  - Nos
  - nos
  - Shc
  - mapP
  - Glucose
---
